Cargando…

Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer

BACKGROUND: Fibronectin 1 (FN1) is a glycoprotein involved in cellular adhesion and migration processes. The aim of this study was to elucidate the role of FN1 in development of renal cell cancer (RCC) and to determine a prognostic relevance for optimal clinical management. METHODS: 212 renal tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Waalkes, Sandra, Atschekzei, Faranaz, Kramer, Mario W, Hennenlotter, Jörg, Vetter, Gesa, Becker, Jan U, Stenzl, Arnulf, Merseburger, Axel S, Schrader, Andres J, Kuczyk, Markus A, Serth, Jürgen
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2949811/ https://www.ncbi.nlm.nih.gov/pubmed/20860816 http://dx.doi.org/10.1186/1471-2407-10-503

Ejemplares similares

Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer
por: Tezval, Hossein, et al.
Publicado: (2013)

Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis
por: Tezval, Hossein, et al.
Publicado: (2016)

GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma
por: PETERS, INGA, et al.
Publicado: (2014)

Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma
por: Peters, Inga, et al.
Publicado: (2014)

Galectin-1 and Galectin-3 mRNA expression in renal cell carcinoma
por: von Klot, Christoph-A, et al.
Publicado: (2014)

Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)
por: Nicklas, André P., et al.
Publicado: (2018)

Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response
por: Dubrowinskaja, Natalia, et al.
Publicado: (2014)

Surgical approach in patients with T4 bladder cancer as primary treatment: Disaster or option with improved quality of life
por: Nagele, Udo, et al.
Publicado: (2008)

Caveolin 1 protein expression in renal cell carcinoma predicts survival
por: Steffens, Sandra, et al.
Publicado: (2011)

Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue
por: Serth, Jürgen, et al.
Publicado: (2020)

Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: disruption of an endogenous inhibitor of angiogenesis and proliferation
por: Tezval, Hossein, et al.
Publicado: (2009)

RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma
por: Tezval, Hossein, et al.
Publicado: (2008)

Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma
por: Gebauer, K, et al.
Publicado: (2013)

Age-Related DNA Methylation in Normal Kidney Tissue Identifies Epigenetic Cancer Risk Susceptibility Loci in the ANKRD34B and ZIC1 Genes
por: Serth, Jürgen, et al.
Publicado: (2022)

RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis
por: Peters, Inga, et al.
Publicado: (2007)

DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies
por: Peters, Inga, et al.
Publicado: (2014)

DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
por: Katzendorn, Olga, et al.
Publicado: (2021)

DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma
por: Katzendorn, Olga, et al.
Publicado: (2021)

Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer
por: Katzendorn, Olga, et al.
Publicado: (2022)

Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS)
por: Serth, Jürgen, et al.
Publicado: (2022)

Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature
por: Kramer, Mario W., et al.
Publicado: (2012)

Development of a clinical algorithm for treating urethral strictures based on a large retrospective single-center cohort
por: Tolkach, Yuri, et al.
Publicado: (2017)

Oncological validation of bone turnover markers c-terminal telopeptide of type I collagen (1CTP) and peptides n-terminal propeptide of type I procollagen (P1NP) in patients with prostate cancer and bone metastases
por: Aufderklamm, Stefan, et al.
Publicado: (2021)

Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation
por: Stickel, Juliane S, et al.
Publicado: (2011)

Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy
por: Hogh-Binder, Sophia A., et al.
Publicado: (2023)

Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes
por: Sittig, Simone P, et al.
Publicado: (2013)

Hemopatch(®) as a Hemostatic Agent is Safe in Partial Nephrectomy: A Large, Single-Surgeon Retrospective Evaluation
por: Hupe, Marie C., et al.
Publicado: (2020)

Identification of variants in genes associated with autoinflammatory disorders in a cohort of patients with psoriatic arthritis
por: Atschekzei, Faranaz, et al.
Publicado: (2022)

Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Carcinoma
por: Faraj Tabrizi, Pouriya, et al.
Publicado: (2023)

Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy
por: von Klot, Christoph A., et al.
Publicado: (2017)

Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity
por: Sogkas, Georgios, et al.
Publicado: (2021)

Primary antibody deficiency-associated arthritis shares features with spondyloarthritis and enteropathic arthritis
por: Pott, Nina Mee, et al.
Publicado: (2022)

Prospective evaluation of fluorescence-guided cystoscopy to detect bladder cancer in a high-risk population: results from the UroScreen-Study
por: Horstmann, Marcus, et al.
Publicado: (2014)

Assessment of a new point-of-care system for detection of prostate specific antigen
por: Rausch, Steffen, et al.
Publicado: (2016)

Systemic Alterations of Wnt Inhibitors in Patients with Prostate Cancer and Bone Metastases
por: Aufderklamm, Stefan, et al.
Publicado: (2018)

Intratumoral Heterogeneity Determines the Expression of mTOR-pathway Proteins in Prostate Cancer
por: Russo, Giorgio Ivan, et al.
Publicado: (2019)

Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases
por: Maas, Moritz, et al.
Publicado: (2023)

Vulnerability to Meningococcal Disease in Immunodeficiency Due to a Novel Pathogenic Missense Variant in NFKB1
por: Anim, Manfred, et al.
Publicado: (2021)

Corrigendum: Vulnerability to meningococcal disease in immunodeficiency due to a novel pathogenic missense variant in NFKB1
por: Anim, Manfred, et al.
Publicado: (2023)

Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer
por: Hupe, Marie C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_690ourqqvulf454v4gdnijj3ov